We have located links that may give you full text access.
Effects of implementing a routine postpartum fasting blood glucose on the completion of the gold standard 2-hour oral glucose tolerance test in gestational diabetics.
American Journal of Perinatology 2024 April 25
OBJECTIVE: Rates of completion of the gold standard 2-hour oral glucose tolerance test (OGTT) for impaired glucose intolerance postpartum in patients with gestational diabetes mellitus (GDM) are consistently less than 50 percent. Screening tests performed prior to hospital discharge, including a fasting blood glucose (FBG) to detect persistent hyperglycemia, have been investigated. We lack evidence, however, on whether implementation of routine postpartum FBG impacts the likelihood of obtaining the routine 2-hour OGTT. We sought to retrospectively compare the rates of completion of the 2-hour OGTT pre- and post-implementation of a routine FBG screen.
STUDY DESIGN: We performed a single-center retrospective cohort study comparing the completion of the 2-hour OGTT pre- and post-implementation of a routine FBG screen. Our primary outcome was completion of the postpartum OGTT. Bivariate analyses assessed associations of demographic and pre-induction clinical characteristics by pre- and post-implementation groups, as well as OGTT completion. Multivariable logistic regression was used to control for possible confounders. A sensitivity analysis was performed to account for the overlap with the COVID pandemic.
RESULTS: 468 patients met inclusion and exclusion criteria. In our post-intervention group, 64% of patients completed a postpartum FBG. For our primary outcome, completion of the 2-hour OGTT significantly decreased in our post-intervention group from 37.1% to 25.9% (p=0.009), aOR 0.62 CI[0.41 - 0.92]. This difference was no longer statistically significant when excluding patients during the pandemic, from 40.3% to 33.1% (p=0.228), aOR 0.76 CI[0.455 - 1.27].
CONCLUSIONS: Implementation of a routine FBG was associated with a negative impact on patients completing a 2-hour OGTT. The difference was no longer significant when excluding patients who would have obtained the OGTT during the pandemic, which may have been due to the smaller cohort. Future work should investigate patient perceptions of the FBG and its impact on their decision-making around the OGTT.
STUDY DESIGN: We performed a single-center retrospective cohort study comparing the completion of the 2-hour OGTT pre- and post-implementation of a routine FBG screen. Our primary outcome was completion of the postpartum OGTT. Bivariate analyses assessed associations of demographic and pre-induction clinical characteristics by pre- and post-implementation groups, as well as OGTT completion. Multivariable logistic regression was used to control for possible confounders. A sensitivity analysis was performed to account for the overlap with the COVID pandemic.
RESULTS: 468 patients met inclusion and exclusion criteria. In our post-intervention group, 64% of patients completed a postpartum FBG. For our primary outcome, completion of the 2-hour OGTT significantly decreased in our post-intervention group from 37.1% to 25.9% (p=0.009), aOR 0.62 CI[0.41 - 0.92]. This difference was no longer statistically significant when excluding patients during the pandemic, from 40.3% to 33.1% (p=0.228), aOR 0.76 CI[0.455 - 1.27].
CONCLUSIONS: Implementation of a routine FBG was associated with a negative impact on patients completing a 2-hour OGTT. The difference was no longer significant when excluding patients who would have obtained the OGTT during the pandemic, which may have been due to the smaller cohort. Future work should investigate patient perceptions of the FBG and its impact on their decision-making around the OGTT.
Full text links
Related Resources
Trending Papers
Systemic lupus erythematosus.Lancet 2024 April 18
Should renin-angiotensin system inhibitors be held prior to major surgery?British Journal of Anaesthesia 2024 May
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.International Journal of Molecular Sciences 2024 April 13
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app